SCHEMBL7849862

SCHEMBL7849862

CC(=O)N(CC(=O)N(C)C)c1[c]cccc1

nearest known ligand 0.36

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 1/20 0.36
OPRL1 P41146 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.33
TSPO P30536 1/20 0.32
ALDH1A1 P00352 2/20 0.31
CYP2D6 P10635 1/20 0.31
OPRK1 P41145 1/20 0.31
L3MBTL1 Q9Y468 2/20 0.30
NPC1 O15118 2/20 0.30
RAB9A P51151 2/20 0.30
NR4A1 P22736 1/20 0.30
NR4A2 P43354 1/20 0.30
NR4A3 Q92570 1/20 0.30
MEN1 O00255 1/20 0.30
TSHR P16473 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7849230 0.81 SMN1; SMN2 (0.40) SMN1; SMN2ALDH1A1MEN1TSHRKMT2A
SCHEMBL2536208 0.80 ALDH1A1 (0.43) SMN1; SMN2TSPOALDH1A1L3MBTL1NPC1
SCHEMBL7849505 0.79 HTR2C (0.40) OPRM1SMN1; SMN2TSPOALDH1A1MEN1
Phenylacetylglycine Dimethylamide SCHEMBL6056919 0.75 ALDH1A1 (0.49) OPRM1OPRL1SMN1; SMN2TSPOALDH1A1
SCHEMBL7849283 0.75 ALDH1A1 (0.36) OPRM1OPRL1SMN1; SMN2ALDH1A1NR4A1
SCHEMBL95841 0.74 ALDH1A1 (0.39) OPRM1OPRL1SMN1; SMN2TSPOALDH1A1
SCHEMBL7801492 0.74 ALDH1A1 (0.44) ALDH1A1MEN1TSHRKMT2A
SCHEMBL2538996 0.72 ALDH1A1 (0.44) OPRM1TSPOALDH1A1NPC1RAB9A
SCHEMBL7839570 0.72 KDM4E (0.38) ALDH1A1NPC1RAB9ANR4A1KMT2A
SCHEMBL3120587 0.72 GAA (0.41) OPRM1OPRL1SMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1115704-A1 NOVEL SUBSTITUTED INDOLINONES WITH AN INHIBITORY EFFECT ON VARIOUS KINASES AND CYCLIN/CDK COMPLEXES Boehringer Ingelheim Pharma KG (DE) 2001-07-18 EP disclosed
WO-2000018734-A1 NOVEL SUBSTITUTED INDOLINONES WITH AN INHIBITORY EFFECT ON VARIOUS KINASES AND CYCLIN/CDK COMPLEXES BOEHRINGER INGELHEIM PHARMA KG (DE) 2000-04-06 WO disclosed